<h4>Background</h4>The association between glucagon-like peptide-1 receptor agonists (GLP-1RAs) and the risk of erectile dysfunction (ED) in men with type 2 diabetes (T2D) remains unclear. This evidence concerns the gene GLP1R and erectile dysfunction.